The latest news in cancer research, health and policy by Cancer Research UK.
We cover developments in cancer treatments, research into cancer risk and diagnosis as well as the latest cancer science stories. You'll also find analysis and comment on health and cancer policy.
Head And Neck Cancers
Some people with head and neck cancer will now have access to the immunotherapy drug pembrolizumab (Keytruda) on the NHS in England.
Leukaemia and head and neck cancer drugs have not been recommended for NHS use in England.
Tackling side effects in head and neck cancer treatment – the end of the road for hyperbaric oxygen?
Hyperbaric oxygen therapy has been used for years to prevent a side effect of head and neck cancer treatment called osteoradionecrosis. But does it work?
Standard chemotherapy remains the most effective way to treat a particular form of throat cancer, according to new research.
A trial to test an experimental drug in patients with head and neck cancer launches in the UK through the Combinations Alliance.
An immunotherapy drug is too expensive to be given to NHS patients with head and neck cancers in England, according to the NHS drugs watchdog.
Several new immunotherapy drugs are continuing to show benefits across a range of cancer types, according to data presented at a US conference.
We take a look at our latest immunotherapy clinical trial, testing a new drug for people with head and neck cancers.
Cancer Research UK has launched a new clinical trial to test a drug that could stop a patient’s immune system from protecting tumours.